vs
Side-by-side financial comparison of Target Hospitality Corp. (TH) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
Twist Bioscience Corp is the larger business by last-quarter revenue ($103.7M vs $73.5M, roughly 1.4× Target Hospitality Corp.). Target Hospitality Corp. runs the higher net margin — -20.3% vs -29.4%, a 9.1% gap on every dollar of revenue. On growth, Target Hospitality Corp. posted the faster year-over-year revenue change (22.0% vs 16.9%).
Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
TH vs TWST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $73.5M | $103.7M |
| Net Profit | $-14.9M | $-30.5M |
| Gross Margin | 9.6% | 52.0% |
| Operating Margin | -22.9% | -31.7% |
| Net Margin | -20.3% | -29.4% |
| Revenue YoY | 22.0% | 16.9% |
| Net Profit YoY | -219.1% | 3.4% |
| EPS (diluted) | $-0.14 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $73.5M | $103.7M | ||
| Q3 25 | $91.6M | — | ||
| Q2 25 | $54.9M | — | ||
| Q1 25 | $54.9M | — | ||
| Q4 24 | $60.2M | — | ||
| Q3 24 | $65.8M | — | ||
| Q2 24 | $67.5M | — | ||
| Q1 24 | $72.4M | — |
| Q4 25 | $-14.9M | $-30.5M | ||
| Q3 25 | $-795.0K | — | ||
| Q2 25 | $-14.9M | — | ||
| Q1 25 | $-6.5M | — | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $20.0M | — | ||
| Q2 24 | $18.4M | — | ||
| Q1 24 | $20.4M | — |
| Q4 25 | 9.6% | 52.0% | ||
| Q3 25 | 19.6% | — | ||
| Q2 25 | -0.6% | — | ||
| Q1 25 | 32.7% | — | ||
| Q4 24 | 61.5% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 69.4% | — | ||
| Q1 24 | 67.8% | — |
| Q4 25 | -22.9% | -31.7% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | -30.8% | — | ||
| Q1 25 | -2.0% | — | ||
| Q4 24 | 34.5% | — | ||
| Q3 24 | 42.5% | — | ||
| Q2 24 | 43.8% | — | ||
| Q1 24 | 42.0% | — |
| Q4 25 | -20.3% | -29.4% | ||
| Q3 25 | -0.9% | — | ||
| Q2 25 | -27.2% | — | ||
| Q1 25 | -11.8% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 30.4% | — | ||
| Q2 24 | 27.2% | — | ||
| Q1 24 | 28.2% | — |
| Q4 25 | $-0.14 | $-0.50 | ||
| Q3 25 | $-0.01 | — | ||
| Q2 25 | $-0.15 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | $0.12 | — | ||
| Q3 24 | $0.20 | — | ||
| Q2 24 | $0.18 | — | ||
| Q1 24 | $0.20 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $197.9M |
| Total DebtLower is stronger | $1.7M | — |
| Stockholders' EquityBook value | $389.3M | $456.1M |
| Total Assets | $530.2M | $638.1M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $197.9M | ||
| Q3 25 | $30.4M | — | ||
| Q2 25 | $19.2M | — | ||
| Q1 25 | $34.5M | — | ||
| Q4 24 | $190.7M | — | ||
| Q3 24 | $177.7M | — | ||
| Q2 24 | $154.3M | — | ||
| Q1 24 | $124.3M | — |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $26.3M | — | ||
| Q1 25 | $42.9M | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $994.0K | — | ||
| Q2 24 | $1.1M | — | ||
| Q1 24 | $179.9M | — |
| Q4 25 | $389.3M | $456.1M | ||
| Q3 25 | $402.4M | — | ||
| Q2 25 | $401.3M | — | ||
| Q1 25 | $415.3M | — | ||
| Q4 24 | $421.1M | — | ||
| Q3 24 | $417.6M | — | ||
| Q2 24 | $397.2M | — | ||
| Q1 24 | $375.5M | — |
| Q4 25 | $530.2M | $638.1M | ||
| Q3 25 | $541.2M | — | ||
| Q2 25 | $533.7M | — | ||
| Q1 25 | $562.5M | — | ||
| Q4 24 | $725.8M | — | ||
| Q3 24 | $709.8M | — | ||
| Q2 24 | $697.0M | — | ||
| Q1 24 | $687.2M | — |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.10× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.48× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.7M | $-24.8M |
| Free Cash FlowOCF − Capex | — | $-34.8M |
| FCF MarginFCF / Revenue | — | -33.5% |
| Capex IntensityCapex / Revenue | — | 9.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.7M | $-24.8M | ||
| Q3 25 | $53.4M | — | ||
| Q2 25 | $11.1M | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $30.6M | — | ||
| Q3 24 | $31.4M | — | ||
| Q2 24 | $39.1M | — | ||
| Q1 24 | $50.6M | — |
| Q4 25 | — | $-34.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -33.5% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -21.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 9.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.44× | — | ||
| Q3 24 | 1.57× | — | ||
| Q2 24 | 2.13× | — | ||
| Q1 24 | 2.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TH
| Services | $40.9M | 56% |
| Hospitality And Facilities Services South | $32.6M | 44% |
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
